TCL Archive Avastin For Adjuvant Treatment Of Colon Cancer Showed Benefit At One Year, But Failed Overall June 5, 2009
TCL Archive Phase II Study Meets Primary Endpoint, Demonstrating Overall Survival of 5.2 Months September 27, 2013